: Eli Lilly’s Mounjaro thrice more practical than Ozempic for weight reduction, real-world examine finds

Eli Lilly’s Mounjaro is considerably more practical than Novo Nordisk’s Ozempic in producing weight reduction in sufferers with chubby or weight problems, a brand new real-world examine discovered.

In an evaluation of 18,000 sufferers, these taking Mounjaro had been thrice extra probably than these taking Ozempic to realize 15% weight reduction, in line with the examine by Truveta Analysis, which analyzes de-identified affected person information from a collective of well being methods. After one 12 months of remedy, the sufferers taking Mounjaro misplaced a mean 15.2% of their…

Grasp your cash.

Subscribe to MarketWatch.

Get this text and all of MarketWatch.

Entry from any gadget. Anyplace. Anytime.


Subscribe Now

Already a subscriber?

Log In

Read More

Vinkmag ad

Read Previous

Financial Report: New-home gross sales drop in October to a lot decrease degree than anticipated

Read Next

School basketball rankings: FAU bounces again after loss to Bryant to win ESPN Occasions Invitational

Leave a Reply

Your email address will not be published. Required fields are marked *

Most Popular